BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ansaldi F, Pugh S, Amicizia D, Di Virgilio R, Trucchi C, Orsi A, Zollo A, Icardi G. Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy. Pathogens 2020;9:E76. [PMID: 31979079 DOI: 10.3390/pathogens9020076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Perdrizet J, Santana CFS, Senna T, Alexandre RF, Sini de Almeida R, Spinardi J, Wasserman M. Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants. Hum Vaccin Immunother 2021;17:1162-72. [PMID: 32966176 DOI: 10.1080/21645515.2020.1809266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Perdrizet J, Santana CFS, Senna T, Alexandre RF, Sini de Almeida R, Spinardi J, Wasserman M. Reply letter to "response to article by Johnna Perdrizet et al." by Gomez and colleagues. Hum Vaccin Immunother 2021;:1-2. [PMID: 33908816 DOI: 10.1080/21645515.2021.1917237] [Reference Citation Analysis]